Amphastar Pharmaceuticals... (AMPH)
23.35
0.36 (1.57%)
At close: Apr 17, 2025, 3:59 PM
23.35
0.00%
After-hours: Apr 17, 2025, 04:07 PM EDT
Amphastar Pharmaceuticals Revenue Breakdown
| Period Ending | Sep 30, 2024 |
|---|---|
| Product and Service, Other Revenue | 2.4M |
| Product and Service, Other Revenue Growth | n/a |
| Product Revenue | 188.82M |
| Product Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 |
|---|---|---|---|---|---|---|
| C Revenue | 3.16M | 1.48M | 279.12M | 234.32M | 249.01M | 243.29M |
| C Revenue Growth | +113.44% | -99.47% | +19.12% | -5.90% | +2.35% | n/a |
| U Revenue | 333.09M | 304.9M | n/a | n/a | n/a | n/a |
| U Revenue Growth | +9.25% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 23.82M | 22.3M | 25.05M | 21.74M | 19.06M | 19M | 20.59M | 16.1M | 16.77M | 15.73M | 17.99M | 14.7M | 15.65M | 18.69M | 19.88M | 15.82M | 15.35M | 19.95M | 14.04M | 13.98M | 14.24M | 15.42M | 19.47M | 16.41M | 15.37M | 13.54M | 12.72M | 10.85M | 13.42M | 13.83M | 12.82M | 12.19M | 12.09M | 10.79M | 12.22M | 10.02M | 10.21M | 12.78M | 13.97M |
| Selling, General, and Administrative Revenue Growth | +6.81% | -10.98% | +15.22% | +14.04% | +0.33% | -7.74% | +27.90% | -3.98% | +6.56% | -12.53% | +22.41% | -6.13% | -16.26% | -5.94% | +25.63% | +3.08% | -23.07% | +42.09% | +0.42% | -1.83% | -7.63% | -20.80% | +18.63% | +6.77% | +13.47% | +6.49% | +17.23% | -19.16% | -2.96% | +7.90% | +5.11% | +0.84% | +12.07% | -11.72% | +22.00% | -1.83% | -20.14% | -8.55% | n/a |
| Research and Development Revenue | 21.08M | 14.53M | 14.23M | 17.85M | 16.66M | 16.84M | 19.82M | 17.24M | 18.51M | 22.8M | 16.22M | 17.29M | 10.76M | 18.12M | 14.77M | 18.13M | 17.64M | 16.15M | 15.3M | 19.64M | 18.61M | 16M | 14.61M | 16.73M | 11.34M | 15.47M | 14.26M | 11.39M | 10.04M | 10.73M | 11.25M | 12.28M | 9.72M | 10.48M | 8.39M | 8.65M | 11.12M | 10.73M | 6.57M |
| Research and Development Revenue Growth | +45.02% | +2.11% | -20.25% | +7.11% | -1.06% | -15.00% | +14.96% | -6.90% | -18.79% | +40.53% | -6.15% | +60.67% | -40.63% | +22.74% | -18.57% | +2.77% | +9.26% | +5.53% | -22.10% | +5.58% | +16.32% | +9.51% | -12.71% | +47.57% | -26.69% | +8.47% | +25.16% | +13.48% | -6.45% | -4.60% | -8.37% | +26.27% | -7.22% | +24.94% | -3.07% | -22.16% | +3.65% | +63.31% | n/a |
| Sales and Marketing Revenue | 8.99M | 9.01M | 9.37M | 8.62M | 6.41M | 6.72M | 7.11M | 5.47M | 4.78M | 5.76M | 5.52M | 4.08M | 4.75M | 4.13M | 4.54M | 3.79M | 3.67M | 4.03M | 3.29M | 3.48M | 3.22M | 2.99M | 3.14M | 2.6M | 1.96M | 1.88M | 1.72M | 1.63M | 1.76M | 1.6M | 1.48M | 1.49M | 1.29M | 1.33M | 1.35M | 1.31M | 1.17M | 1.47M | 1.52M |
| Sales and Marketing Revenue Growth | -0.19% | -3.83% | +8.72% | +34.52% | -4.63% | -5.50% | +29.92% | +14.38% | -16.89% | +4.29% | +35.44% | -14.12% | +14.92% | -8.99% | +19.80% | +3.10% | -8.77% | +22.22% | -5.24% | +7.92% | +7.65% | -4.74% | +20.99% | +32.25% | +4.64% | +9.01% | +5.65% | -7.23% | +10.03% | +7.91% | -0.80% | +15.49% | -3.08% | -1.48% | +3.44% | +11.61% | -20.34% | -3.42% | n/a |